Similar articles for PMID: 24523301

Year	Number of Results
2010	1
2011	1
2012	3
2013	4
2014	6
2015	11
2016	13
2017	21
2018	21
2019	26
2020	28
2021	25
2022	14
2023	7
2024	0

1

Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.

Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, Janes JR, Laidig GJ, Lewis ER, Li J, Mackinnon AL, Parlati F, Rodriguez ML, Shwonek PJ, Sjogren EB, Stanton TF, Wang T, Yang J, Zhao F, Bennett MK. Gross MI, et al. Mol Cancer Ther. 2014 Apr;13(4):890-901. doi: 10.1158/1535-7163.MCT-13-0870. Epub 2014 Feb 12. Mol Cancer Ther. 2014. PMID: 24523301

2

Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer.

Singleton DC, Dechaume AL, Murray PM, Katt WP, Baguley BC, Leung EY. Singleton DC, et al. BMC Cancer. 2020 May 25;20(1):470. doi: 10.1186/s12885-020-06885-3. BMC Cancer. 2020. PMID: 32450839 Free PMC article.

3

Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.

Huang Q, Stalnecker C, Zhang C, McDermott LA, Iyer P, O'Neill J, Reimer S, Cerione RA, Katt WP. Huang Q, et al. J Biol Chem. 2018 Mar 9;293(10):3535-3545. doi: 10.1074/jbc.M117.810101. Epub 2018 Jan 9. J Biol Chem. 2018. PMID: 29317493 Free PMC article.

4

Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.

Reis LMD, Adamoski D, Ornitz Oliveira Souza R, Rodrigues Ascenção CF, Sousa de Oliveira KR, Corrêa-da-Silva F, Malta de Sá Patroni F, Meira Dias M, Consonni SR, Mendes de Moraes-Vieira PM, Silber AM, Dias SMG. Reis LMD, et al. J Biol Chem. 2019 Jun 14;294(24):9342-9357. doi: 10.1074/jbc.RA119.008180. Epub 2019 Apr 30. J Biol Chem. 2019. PMID: 31040181 Free PMC article.

5

The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma.

Emberley E, Pan A, Chen J, Dang R, Gross M, Huang T, Li W, MacKinnon A, Singh D, Sotirovska N, Steggerda SM, Wang T, Parlati F. Emberley E, et al. PLoS One. 2021 Nov 3;16(11):e0259241. doi: 10.1371/journal.pone.0259241. eCollection 2021. PLoS One. 2021. PMID: 34731180 Free PMC article.

6

Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.

Grinde MT, Hilmarsdottir B, Tunset HM, Henriksen IM, Kim J, Haugen MH, Rye MB, Mælandsmo GM, Moestue SA. Grinde MT, et al. Breast Cancer Res. 2019 May 14;21(1):61. doi: 10.1186/s13058-019-1141-0. Breast Cancer Res. 2019. PMID: 31088535 Free PMC article.

7

Glutamate-Weighted Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Detects Glutaminase Inhibition in a Mouse Model of Triple-Negative Breast Cancer.

Zhou R, Bagga P, Nath K, Hariharan H, Mankoff DA, Reddy R. Zhou R, et al. Cancer Res. 2018 Oct 1;78(19):5521-5526. doi: 10.1158/0008-5472.CAN-17-3988. Epub 2018 Aug 2. Cancer Res. 2018. PMID: 30072394 Free PMC article.

8

Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.

Matre P, Velez J, Jacamo R, Qi Y, Su X, Cai T, Chan SM, Lodi A, Sweeney SR, Ma H, Davis RE, Baran N, Haferlach T, Su X, Flores ER, Gonzalez D, Konoplev S, Samudio I, DiNardo C, Majeti R, Schimmer AD, Li W, Wang T, Tiziani S, Konopleva M. Matre P, et al. Oncotarget. 2016 Nov 29;7(48):79722-79735. doi: 10.18632/oncotarget.12944. Oncotarget. 2016. PMID: 27806325 Free PMC article.

9

Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice.

Boysen G, Jamshidi-Parsian A, Davis MA, Siegel ER, Simecka CM, Kore RA, Dings RPM, Griffin RJ. Boysen G, et al. Int J Radiat Biol. 2019 Apr;95(4):436-442. doi: 10.1080/09553002.2018.1558299. Epub 2019 Jan 15. Int J Radiat Biol. 2019. PMID: 30557074 Free PMC article.

10

Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells.

Ju Y, Ben-David Y, Rotin D, Zacksenhaus E. Ju Y, et al. Sci Rep. 2021 Apr 28;11(1):9181. doi: 10.1038/s41598-021-88816-1. Sci Rep. 2021. PMID: 33911160 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

159 results

Results by year